世界のブルガダ症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Brugada Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5638
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ブルガダ症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（大人、子供）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ブルガダ症候群の市場動向
・企業の競争状況、市場シェア
・ブルガダ症候群の種類別市場規模と予測2016-2027（診断、治療）
・ブルガダ症候群の用途別市場規模と予測2016-2027（大人、子供）
・ブルガダ症候群の北米市場規模2016-2027（アメリカ、カナダ）
・ブルガダ症候群の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ブルガダ症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ブルガダ症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・ブルガダ症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GeneDx、PGxHealth、GE Healthcare、Pfizer、Abbott、Medtronic、Boston Scientific、GlaxoSmithKline）
・結論

Brugada syndrome is a genetic condition resulting in an abnormal electrical activity within the heart, which in turn increases the risk of sudden cardiac death.

Market Analysis and Insights: Global Brugada Syndrome Market
The global Brugada Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brugada Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brugada Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brugada Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brugada Syndrome market.

Global Brugada Syndrome Scope and Market Size
Brugada Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brugada Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis
Treatment

Segment by Application
Adult
Child

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GeneDx
PGxHealth
GE Healthcare
Pfizer
Abbott
Medtronic
Boston Scientific
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brugada Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Brugada Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Brugada Syndrome Market Perspective (2016-2027)
2.2 Brugada Syndrome Growth Trends by Regions
2.2.1 Brugada Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brugada Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Brugada Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Brugada Syndrome Industry Dynamic
2.3.1 Brugada Syndrome Market Trends
2.3.2 Brugada Syndrome Market Drivers
2.3.3 Brugada Syndrome Market Challenges
2.3.4 Brugada Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Brugada Syndrome Players by Revenue
3.1.1 Global Top Brugada Syndrome Players by Revenue (2016-2021)
3.1.2 Global Brugada Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Brugada Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brugada Syndrome Revenue
3.4 Global Brugada Syndrome Market Concentration Ratio
3.4.1 Global Brugada Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brugada Syndrome Revenue in 2020
3.5 Brugada Syndrome Key Players Head office and Area Served
3.6 Key Players Brugada Syndrome Product Solution and Service
3.7 Date of Enter into Brugada Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Brugada Syndrome Breakdown Data by Type
4.1 Global Brugada Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Brugada Syndrome Forecasted Market Size by Type (2022-2027)

5 Brugada Syndrome Breakdown Data by Application
5.1 Global Brugada Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Brugada Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Brugada Syndrome Market Size (2016-2027)
6.2 North America Brugada Syndrome Market Size by Type
6.2.1 North America Brugada Syndrome Market Size by Type (2016-2021)
6.2.2 North America Brugada Syndrome Market Size by Type (2022-2027)
6.2.3 North America Brugada Syndrome Market Size by Type (2016-2027)
6.3 North America Brugada Syndrome Market Size by Application
6.3.1 North America Brugada Syndrome Market Size by Application (2016-2021)
6.3.2 North America Brugada Syndrome Market Size by Application (2022-2027)
6.3.3 North America Brugada Syndrome Market Size by Application (2016-2027)
6.4 North America Brugada Syndrome Market Size by Country
6.4.1 North America Brugada Syndrome Market Size by Country (2016-2021)
6.4.2 North America Brugada Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Brugada Syndrome Market Size (2016-2027)
7.2 Europe Brugada Syndrome Market Size by Type
7.2.1 Europe Brugada Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Brugada Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Brugada Syndrome Market Size by Type (2016-2027)
7.3 Europe Brugada Syndrome Market Size by Application
7.3.1 Europe Brugada Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Brugada Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Brugada Syndrome Market Size by Application (2016-2027)
7.4 Europe Brugada Syndrome Market Size by Country
7.4.1 Europe Brugada Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Brugada Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Brugada Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Brugada Syndrome Market Size by Type
8.2.1 Asia-Pacific Brugada Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brugada Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brugada Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Brugada Syndrome Market Size by Application
8.3.1 Asia-Pacific Brugada Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brugada Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brugada Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Brugada Syndrome Market Size by Region
8.4.1 Asia-Pacific Brugada Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brugada Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Brugada Syndrome Market Size (2016-2027)
9.2 Latin America Brugada Syndrome Market Size by Type
9.2.1 Latin America Brugada Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Brugada Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Brugada Syndrome Market Size by Type (2016-2027)
9.3 Latin America Brugada Syndrome Market Size by Application
9.3.1 Latin America Brugada Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Brugada Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Brugada Syndrome Market Size by Application (2016-2027)
9.4 Latin America Brugada Syndrome Market Size by Country
9.4.1 Latin America Brugada Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Brugada Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Brugada Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Brugada Syndrome Market Size by Type
10.2.1 Middle East & Africa Brugada Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brugada Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brugada Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Brugada Syndrome Market Size by Application
10.3.1 Middle East & Africa Brugada Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brugada Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brugada Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Brugada Syndrome Market Size by Country
10.4.1 Middle East & Africa Brugada Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brugada Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GeneDx
11.1.1 GeneDx Company Details
11.1.2 GeneDx Business Overview
11.1.3 GeneDx Brugada Syndrome Introduction
11.1.4 GeneDx Revenue in Brugada Syndrome Business (2016-2021)
11.1.5 GeneDx Recent Development
11.2 PGxHealth
11.2.1 PGxHealth Company Details
11.2.2 PGxHealth Business Overview
11.2.3 PGxHealth Brugada Syndrome Introduction
11.2.4 PGxHealth Revenue in Brugada Syndrome Business (2016-2021)
11.2.5 PGxHealth Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Brugada Syndrome Introduction
11.3.4 GE Healthcare Revenue in Brugada Syndrome Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Brugada Syndrome Introduction
11.4.4 Pfizer Revenue in Brugada Syndrome Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Brugada Syndrome Introduction
11.5.4 Abbott Revenue in Brugada Syndrome Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Brugada Syndrome Introduction
11.6.4 Medtronic Revenue in Brugada Syndrome Business (2016-2021)
11.6.5 Medtronic Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Brugada Syndrome Introduction
11.7.4 Boston Scientific Revenue in Brugada Syndrome Business (2016-2021)
11.7.5 Boston Scientific Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Brugada Syndrome Introduction
11.8.4 GlaxoSmithKline Revenue in Brugada Syndrome Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Brugada Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Brugada Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Brugada Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Brugada Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Brugada Syndrome Market Share by Regions (2016-2021)
Table 8. Global Brugada Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Brugada Syndrome Market Share by Regions (2022-2027)
Table 10. Brugada Syndrome Market Trends
Table 11. Brugada Syndrome Market Drivers
Table 12. Brugada Syndrome Market Challenges
Table 13. Brugada Syndrome Market Restraints
Table 14. Global Brugada Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Brugada Syndrome Market Share by Players (2016-2021)
Table 16. Global Top Brugada Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brugada Syndrome as of 2020)
Table 17. Ranking of Global Top Brugada Syndrome Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Brugada Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Brugada Syndrome Product Solution and Service
Table 21. Date of Enter into Brugada Syndrome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Brugada Syndrome Revenue Market Share by Type (2016-2021)
Table 25. Global Brugada Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Brugada Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Brugada Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Brugada Syndrome Revenue Market Share by Application (2016-2021)
Table 29. Global Brugada Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Brugada Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Brugada Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Brugada Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Brugada Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Brugada Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Brugada Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Brugada Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Brugada Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Brugada Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Brugada Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Brugada Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Brugada Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Brugada Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Brugada Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Brugada Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Brugada Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Brugada Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Brugada Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Brugada Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Brugada Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Brugada Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Brugada Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Brugada Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Brugada Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Brugada Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Brugada Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Brugada Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 61. GeneDx Company Details
Table 62. GeneDx Business Overview
Table 63. GeneDx Brugada Syndrome Product
Table 64. GeneDx Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 65. GeneDx Recent Development
Table 66. PGxHealth Company Details
Table 67. PGxHealth Business Overview
Table 68. PGxHealth Brugada Syndrome Product
Table 69. PGxHealth Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 70. PGxHealth Recent Development
Table 71. GE Healthcare Company Details
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Brugada Syndrome Product
Table 74. GE Healthcare Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Brugada Syndrome Product
Table 79. Pfizer Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Brugada Syndrome Product
Table 84. Abbott Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Brugada Syndrome Product
Table 89. Medtronic Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 90. Medtronic Recent Development
Table 91. Boston Scientific Company Details
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Brugada Syndrome Product
Table 94. Boston Scientific Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 95. Boston Scientific Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Revenue in Brugada Syndrome Business (2016-2021) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brugada Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Brugada Syndrome Market Share by Application: 2020 VS 2027
Figure 5. Adult Case Studies
Figure 6. Child Case Studies
Figure 7. Brugada Syndrome Report Years Considered
Figure 8. Global Brugada Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Brugada Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Brugada Syndrome Market Share by Regions: 2020 VS 2027
Figure 11. Global Brugada Syndrome Market Share by Regions (2022-2027)
Figure 12. Global Brugada Syndrome Market Share by Players in 2020
Figure 13. Global Top Brugada Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brugada Syndrome as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Brugada Syndrome Revenue in 2020
Figure 15. Global Brugada Syndrome Revenue Market Share by Type (2016-2021)
Figure 16. Global Brugada Syndrome Revenue Market Share by Type (2022-2027)
Figure 17. North America Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Brugada Syndrome Market Share by Type (2016-2027)
Figure 19. North America Brugada Syndrome Market Share by Application (2016-2027)
Figure 20. North America Brugada Syndrome Market Share by Country (2016-2027)
Figure 21. United States Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Brugada Syndrome Market Share by Type (2016-2027)
Figure 25. Europe Brugada Syndrome Market Share by Application (2016-2027)
Figure 26. Europe Brugada Syndrome Market Share by Country (2016-2027)
Figure 27. Germany Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Brugada Syndrome Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Brugada Syndrome Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Brugada Syndrome Market Share by Region (2016-2027)
Figure 37. China Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Brugada Syndrome Market Share by Type (2016-2027)
Figure 45. Latin America Brugada Syndrome Market Share by Application (2016-2027)
Figure 46. Latin America Brugada Syndrome Market Share by Country (2016-2027)
Figure 47. Mexico Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Brugada Syndrome Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Brugada Syndrome Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Brugada Syndrome Market Share by Country (2016-2027)
Figure 53. Turkey Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Brugada Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. GeneDx Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 57. PGxHealth Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 58. GE Healthcare Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 62. Boston Scientific Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Brugada Syndrome Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5003 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年）

Global Bronchiolitis Obliterans Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-3944 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、閉塞性細気管支炎症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（吸入式、経口式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…
世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年） Goodpasture syndrome may be caused by viral infection and / or inhalation of certain chemical substances causing primary lung damage. Market Analysis and Insights: Global Goodpasture Syndrome Treatment Market The global Goodpasture Syndrome Treatment market size is projected to reach US$ XX million …